Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:

Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.

Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.

Tom Fuchs, MD, PhD, a research fellow at the MS Center at Amsterdam University Medical Center.

Barry Singer, MD, the director and founder of The MS Center for Innovations in Care.

Georgina Arrambide, a clinical neurologist in the MS Center of Catalunya.

Episode Breakdown:

1:10 – Joi Williams on expanding the use of biomarkers and the next steps in advancing precision medicine for multiple sclerosis treatment.

2:20 – Voskuhl on the increased research efforts to better understand the links between aging, menopause, and women with MS.

4:30 – Fuchs on the challenges of tracking cognitive decline in multiple sclerosis and improving currently available assessments.

7:50 – Singer on the introduction of biosimilars to MS care, the rigorous approval process they undergo, and the potential benefits they bring to the field.

11:45 – Arrambide on an updated consensus approach to the differential diagnosis of suspected multiple sclerosis, and the red flags clinicians should be aware of during this process.

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.

Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.